Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis

Keiichi Asano, Courtney M. Nelson, Sumeda Nandadasa, Noriko Aramaki, Daniel J. Lindner, Tyler Alban, Junko Inagaki, Takashi Ohtsuki, Toshitaka Oohashi, Suneel S. Apte, Satoshi Hirohata

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The proteoglycan versican is implicated in growth and metastases of several cancers. Here we investigated a potential contribution of stromal versican to tumor growth and angiogenesis. We initially determined versican expression by several cancer cell lines. Among these, MDA-MB231 and B16F10 had none to minimal expression in contrast to Lewis lung carcinoma (LLC). Notably, tumors arising from these cell lines had higher versican levels than the cell lines themselves suggesting a contribution from the host-derived tumor stroma. In LLC-derived tumors, both the tumor and stroma expressed versican at high levels. Thus, tumor stroma can make a significant contribution to tumor versican content. Versican localized preferentially to the vicinity of tumor vasculature and macrophages in the tumor. However, an ADAMTS protease-generated versican fragment uniquely localized to vascular endothelium. To specifically determine the impact of host/stroma-derived versican we therefore compared growth of tumors from B16F10 cells, which produced littleversican, in Vcan hdf/+ mice and wild-type littermates. Tumors in Vcan hdf/+ mice had reduced growth with a lower capillary density and accumulation of capillaries at the tumor periphery. These findings illustrate the variability of tumor cell line expression of versican, and demonstrate that versican is consistently contributed by the stromal tissue, where it contributes to tumor angiogenesis.

Original languageEnglish
Article number17225
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1
Externally publishedYes

Fingerprint

Versicans
Growth
Neoplasms
Lewis Lung Carcinoma
Tumor Cell Line
Cell Line
Vascular Endothelium
Proteoglycans

ASJC Scopus subject areas

  • General

Cite this

Asano, K., Nelson, C. M., Nandadasa, S., Aramaki, N., Lindner, D. J., Alban, T., ... Hirohata, S. (2017). Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis. Scientific Reports, 7(1), [17225]. https://doi.org/10.1038/s41598-017-17613-6

Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis. / Asano, Keiichi; Nelson, Courtney M.; Nandadasa, Sumeda; Aramaki, Noriko; Lindner, Daniel J.; Alban, Tyler; Inagaki, Junko; Ohtsuki, Takashi; Oohashi, Toshitaka; Apte, Suneel S.; Hirohata, Satoshi.

In: Scientific Reports, Vol. 7, No. 1, 17225, 01.12.2017.

Research output: Contribution to journalArticle

Asano, K, Nelson, CM, Nandadasa, S, Aramaki, N, Lindner, DJ, Alban, T, Inagaki, J, Ohtsuki, T, Oohashi, T, Apte, SS & Hirohata, S 2017, 'Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis', Scientific Reports, vol. 7, no. 1, 17225. https://doi.org/10.1038/s41598-017-17613-6
Asano, Keiichi ; Nelson, Courtney M. ; Nandadasa, Sumeda ; Aramaki, Noriko ; Lindner, Daniel J. ; Alban, Tyler ; Inagaki, Junko ; Ohtsuki, Takashi ; Oohashi, Toshitaka ; Apte, Suneel S. ; Hirohata, Satoshi. / Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{f81338d878c94aa2802a2c8883dc4ca0,
title = "Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis",
abstract = "The proteoglycan versican is implicated in growth and metastases of several cancers. Here we investigated a potential contribution of stromal versican to tumor growth and angiogenesis. We initially determined versican expression by several cancer cell lines. Among these, MDA-MB231 and B16F10 had none to minimal expression in contrast to Lewis lung carcinoma (LLC). Notably, tumors arising from these cell lines had higher versican levels than the cell lines themselves suggesting a contribution from the host-derived tumor stroma. In LLC-derived tumors, both the tumor and stroma expressed versican at high levels. Thus, tumor stroma can make a significant contribution to tumor versican content. Versican localized preferentially to the vicinity of tumor vasculature and macrophages in the tumor. However, an ADAMTS protease-generated versican fragment uniquely localized to vascular endothelium. To specifically determine the impact of host/stroma-derived versican we therefore compared growth of tumors from B16F10 cells, which produced littleversican, in Vcan hdf/+ mice and wild-type littermates. Tumors in Vcan hdf/+ mice had reduced growth with a lower capillary density and accumulation of capillaries at the tumor periphery. These findings illustrate the variability of tumor cell line expression of versican, and demonstrate that versican is consistently contributed by the stromal tissue, where it contributes to tumor angiogenesis.",
author = "Keiichi Asano and Nelson, {Courtney M.} and Sumeda Nandadasa and Noriko Aramaki and Lindner, {Daniel J.} and Tyler Alban and Junko Inagaki and Takashi Ohtsuki and Toshitaka Oohashi and Apte, {Suneel S.} and Satoshi Hirohata",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-17613-6",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis

AU - Asano, Keiichi

AU - Nelson, Courtney M.

AU - Nandadasa, Sumeda

AU - Aramaki, Noriko

AU - Lindner, Daniel J.

AU - Alban, Tyler

AU - Inagaki, Junko

AU - Ohtsuki, Takashi

AU - Oohashi, Toshitaka

AU - Apte, Suneel S.

AU - Hirohata, Satoshi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The proteoglycan versican is implicated in growth and metastases of several cancers. Here we investigated a potential contribution of stromal versican to tumor growth and angiogenesis. We initially determined versican expression by several cancer cell lines. Among these, MDA-MB231 and B16F10 had none to minimal expression in contrast to Lewis lung carcinoma (LLC). Notably, tumors arising from these cell lines had higher versican levels than the cell lines themselves suggesting a contribution from the host-derived tumor stroma. In LLC-derived tumors, both the tumor and stroma expressed versican at high levels. Thus, tumor stroma can make a significant contribution to tumor versican content. Versican localized preferentially to the vicinity of tumor vasculature and macrophages in the tumor. However, an ADAMTS protease-generated versican fragment uniquely localized to vascular endothelium. To specifically determine the impact of host/stroma-derived versican we therefore compared growth of tumors from B16F10 cells, which produced littleversican, in Vcan hdf/+ mice and wild-type littermates. Tumors in Vcan hdf/+ mice had reduced growth with a lower capillary density and accumulation of capillaries at the tumor periphery. These findings illustrate the variability of tumor cell line expression of versican, and demonstrate that versican is consistently contributed by the stromal tissue, where it contributes to tumor angiogenesis.

AB - The proteoglycan versican is implicated in growth and metastases of several cancers. Here we investigated a potential contribution of stromal versican to tumor growth and angiogenesis. We initially determined versican expression by several cancer cell lines. Among these, MDA-MB231 and B16F10 had none to minimal expression in contrast to Lewis lung carcinoma (LLC). Notably, tumors arising from these cell lines had higher versican levels than the cell lines themselves suggesting a contribution from the host-derived tumor stroma. In LLC-derived tumors, both the tumor and stroma expressed versican at high levels. Thus, tumor stroma can make a significant contribution to tumor versican content. Versican localized preferentially to the vicinity of tumor vasculature and macrophages in the tumor. However, an ADAMTS protease-generated versican fragment uniquely localized to vascular endothelium. To specifically determine the impact of host/stroma-derived versican we therefore compared growth of tumors from B16F10 cells, which produced littleversican, in Vcan hdf/+ mice and wild-type littermates. Tumors in Vcan hdf/+ mice had reduced growth with a lower capillary density and accumulation of capillaries at the tumor periphery. These findings illustrate the variability of tumor cell line expression of versican, and demonstrate that versican is consistently contributed by the stromal tissue, where it contributes to tumor angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=85042385173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042385173&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-17613-6

DO - 10.1038/s41598-017-17613-6

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 17225

ER -